- 专利标题： Tricyclic compounds as anticancer agents
-
申请号： US15219611申请日： 2016-07-26
-
公开(公告)号： US09751879B2公开(公告)日： 2017-09-05
- 发明人: Derek J. Norris , George V. Delucca , Ashvinikumar V. Gavai , Claude A. Quesnelle , Patrice Gill , Daniel O'Malley , Wayne Vaccaro , Francis Y. Lee , Mikkel V. DeBenedetto , Andrew P. Degnan , Haiquan Fang , Matthew D. Hill , Hong Huang , William D. Schmitz , John E. Starrett, Jr. , Wen-Ching Han , John S. Tokarski , Sunil Kumar Mandal
- 申请人： BRISTOL-MYERS SQUIBB COMPANY
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Elliott Korsen
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437
摘要：
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
公开/授权文献
- US20160326173A1 NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS 公开/授权日：2016-11-10
信息查询
